000 01435 a2200361 4500
005 20250518092128.0
264 0 _c20210414
008 202104s 0 0 eng d
022 _a1879-0887
024 7 _a10.1016/j.radonc.2020.02.015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aXu, Cai
245 0 0 _aThe impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy.
_h[electronic resource]
260 _bRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_c05 2020
300 _a180-186 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aChemoradiotherapy
_xadverse effects
650 0 4 _aEsophageal Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLymphopenia
_xetiology
650 0 4 _aProgression-Free Survival
650 0 4 _aProportional Hazards Models
650 0 4 _aRetrospective Studies
700 1 _aJin, Jian-Yue
700 1 _aZhang, Ming
700 1 _aLiu, Amy
700 1 _aWang, Jun
700 1 _aMohan, Radhe
700 1 _aKong, Fengming Spring
700 1 _aLin, Steven H
773 0 _tRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_gvol. 146
_gp. 180-186
856 4 0 _uhttps://doi.org/10.1016/j.radonc.2020.02.015
_zAvailable from publisher's website
999 _c30751269
_d30751269